Mark Bartlett is an expert in pharmacogenomics, the study of how a person’s genes affect their response to drugs. He is also the founder of the health startup Geneix, which was named ‘Most Disruptive Startup’ in 2014 by TechCity News. Geneix has been trying to bring the use of pharmacogenomics into mainstream healthcare. Mark talked…